CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 132 enrolled
Drug / intervention
Warfarindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03103763
NCT03103763N/ACompleted
CompareCT.gov

ATIVO Study - Anticoagulation Therapy in the Very Old

Robert Stein·observational·Posted Apr 6, 2017·Updated Aug 17, 2021

In Brief

An observational study evaluating Warfarin for Atrial Fibrillation. Completed, enrolled 132 participants across 1 site.

Detailed Summary

This study is designed to evaluate the efficacy and safety of warfarin anticoagulation in the very old and attempt to identify risk factors which may impede safe and effective anticoagulation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 6, 2017
Enrollment StartMar 20, 2017
Primary CompletionSep 3, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.2 years ago

Interventions

Warfarindrug

Patients on warfarin for atrial fibrillation